| Trial ID: | L0920 |
| Source ID: | IRCT201305254105N12
|
| Associated Drug: |
Coenzyme Q10
|
| Title: |
The Effect of coenzyme Q10 on serum concentrations of pentraxin 3 and metabolic parameters in non-alcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic fatty liver disease. <br>Other diseases of liver;Other diseases of liver
|
| Interventions: |
Intervention 1: One 100 milligram capsule each day for 4 weeks. Intervention 2: One capsule containing starch each day for 4 weeks.;Treatment - Drugs;Placebo;One 100 milligram capsule each day for 4 weeks;One capsule containing starch each day for 4 weeks
|
| Outcome Measures: |
Liver Enzymes(ALT,AST). Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Autoanalyzer.;Total Cholesterol. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Spectrophotometry.;Triglyceride. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Spectrophotometry.;HDL. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Spectrophotometry.;LDL. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Friedewald Formula.;Insulin. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: ELIZA.;HOMA-IR. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Formula.;Fasting Blood Sugar. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Spectrophotometry.;AST/ALT. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Formula.;Pentraxin 3. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: ELIZA.Food intake. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: dietary record questionnaire.;Body Mass Index. Timepoint: At baseine and after 4 weeks of intervention. Method of measurement: Scales and meters.
|
| Sponsor/Collaborators: |
Vice chancellor for Research, Tabriz University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years65 years
|
| Phases: |
Phase 2
|
| Enrollment: |
44
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
15/06/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/4308
|
